Nucleai

Nuclei is an Israeli healthtech company focused on AI-based analysis of digital pathology images, with a primary emphasis on oncology-related tissue analysis. Detailed public information about the company — including founding year, founders' names, employee count, exact headquarters city, and funding history — is limited in what I can confirm with certainty for this specific company.

The company develops tools for analyzing biopsies and digital pathology images to help researchers and pharmaceutical companies identify biomarkers relevant to drug development and clinical research. Its likely primary buyers are large pharma companies and clinical research institutions, though I have no verified knowledge of specific named customers.